Information platform for Japanese Medicines

Susoctocog Alfa (Genetical Recombination) as Active ingredient

OBIZUR Intravenous Injection 500
Medicine name

OBIZUR Intravenous Injection 500

Active ingredient
Susoctocog Alfa (Genetical Recombination)
Manufacturer
Takeda Pharmaceutical Company Limited
Category
Agents against pathologic organisms and parasites
Login required
Tags
Please add the drug you wish to request a quote for to your My List.
Have an account?

An account is required to quote and purchase products.

Search Options
Current conditions:
Select categories
Filter clear

This website is available exclusively to healthcare professionals outside of Japan.

Registration and use by the general public are not permitted. Upon member registration, we will verify your credentials related to pharmaceutical transactions.

Are you a healthcare professional outside of Japan?